Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • VenoraTheBarbarian@lemmy.worldEnglish
    25·
    1 year ago

    That’s an excellent argument for why we should have a nationally owned pharmaceutical option. The US government funds a bunch of the research anyway, we should just own production lines as well. Cut out the middle men.

    We should set it up as USPS-like competition for the pharmaceutical industry. Then they can change what ever the fuck they want without literally killing people, cuz there will be a publicly owned backup.